PNAGF yields 4.42% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PNAGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PNAGF + PFE for your $10,000?
PETRONAS Gas Berhad operates as a gas infrastructure and utilities company in Malaysia. The company engages in separating natural gas into components; and storing, transporting, distributing, and selling such components to industrial utilities. It operates through four segments: Gas Processing, Gas Transportation, Regasification, and Utilities. The Gas Processing segment processes natural gas from the gas fields of the East Coast of Peninsular Malaysia into sales gas and other by-products, such as ethane, propane, and butane. The Gas Transportation segment engages in the transportation of sales gas through its 2,623 kilometers of peninsular gas utilization pipeline network, as well as pengerang gas pipeline network. It also transports small volumes of sales gas through its gas distribution system in Miri and Bintulu, and Sarawak; exports sales gas to Singapore; and offers operation and maintenance services. The Regasification segment engages in the regasification of liquefied natural gas (LNG), as well as provides LNG reloading, truck loading, and gassing up and cooling down services. The Utilities segment manufactures, markets, and supplies industrial utilities to the petrochemical complexes in the Kertih and Gebeng Industrial Area. This segment offers electricity, steam, and industrial gases; and operations and maintenance services, as well as other utility products, such as oxygen, nitrogen, demineralized water, raw water, cooling water, and boiler feed water to petrochemical complexes and national electricity grid. The company was incorporated in 1983 and is based in Kuala Lumpur, Malaysia. PETRONAS Gas Berhad is a subsidiary of Petroliam Nasional Berhad.
Full PNAGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.